- Home
- Â /Â DaVita
DaVita
Stock Price
$98.3
2023-09-15
Market Capitalization
$9 B
2023-09-15
Revenue
$11.6 B
FY, 2022
DaVita Summary
Company Summary
- Overview
- DaVita is a kidney care company focused on dialysis and related lab services. It has expertise in hemodialysis, peritoneal dialysis, and kidney transplantation. The company provides outpatient hemodialysis services, hospital inpatient hemodialysis services, and home-based dialysis services, ESRD laboratory services, and management services. It operates several outpatient dialysis centers worldwide.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Denver, CO, US | view all locations
- Website
- https://www.davita.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Barbara J Desoer, Director
Charles G Berg, Former Chief Executive Officer, Citibank, N.A.
George R Aronoff, Vice President of Clinical Affairs, Kidney Care
Operating MetricsView all
Hospitals
900
FY, 2019
Dialysis Centers
2.8K
3.3%
FY, 2019
Dialysis Centers Opened Year to Date
89
42.2%
FY, 2019
LocationsView all
19 locations detected
Denver, COÂ HQ
United States
2000 16th St Mall
Brentwood, TN
United States
5200 Virginia Way
Centennial, CO
United States
7173 S Havana St #100
DeLand, FL
United States
3000 Davita Way
Denver, CO
United States
1551 Wewatta St
El Segundo, CA
United States
601 Hawaii St
DaVita Financials
Summary Financials
- Revenue (Q2, 2023)
- $3.0B
- Net income (Q2, 2023)
- $246.4M
- Cash (Q2, 2023)
- $327.4M
- EBIT (Q2, 2023)
- $405.3M
- Enterprise value
- $17.3B